Related Experiment Video
Updated: Dec 18, 2025

Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System
Published on: March 20, 2016
PTPIP51 crosslinks the NFκB signaling and the MAPK pathway in SKBR3 cells
Eric Dietel1, Alexander Brobeil2, Claudia Tag1
1Institute of Anatomy & Cell Biology, Justus-Liebig-University, Giessen 35392, Germany.
Aim:
PTPIP51 interacts with NFκB signaling at the RelA and IκB level. NFκB signaling is linked to the initiation, progression and metastasis of breast cancer. Her2-amplified breast cancer cells frequently display activation of the NFκB signaling. We aimed to clarify the effects of NFκB inhibition on the NFκB- and MAPK-related interactome of PTPIP51 and cell viability in HaCat cells and SKBR3 cells.
Results:
IKK-16 selectively reduced cell viability in SKBR3 cells. PDTC induced a formation of the Raf1/14-3-3/PTPIP51 complex in SKBR3 cells, indicating a shift of PTPIP51 into MAPK signaling.
Conclusion:
IKK-16 selectively inhibits cell viability of SKBR3 cells. In addition, PTPIP51 might serve as the mediator between NFκB signaling and the MAPK pathway in SKBR3.
Insights
NFκB inhibition selectively reduced SKBR3 breast cancer cell viability. PTPIP51 protein may mediate between NFκB and MAPK pathways, impacting cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Nuclear factor kappa B (NFκB) signaling is implicated in breast cancer initiation, progression, and metastasis.
- Her2-amplified breast cancer often exhibits activated NFκB signaling.
- PTPIP51 protein is known to interact with NFκB signaling components.
Purpose of the Study:
- To investigate the effects of NFκB inhibition on the PTPIP51 interactome within NFκB and MAPK signaling pathways.
- To assess the impact of NFκB inhibition on cell viability in HaCat and SKBR3 cells.
Main Methods:
- Utilized IKK-16 and PDTC as NFκB inhibitors.
- Analyzed PTPIP51 protein interactions within NFκB and MAPK pathways.
- Assessed cell viability in HaCat and SKBR3 cell lines.
Main Results:
- IKK-16 selectively reduced cell viability in SKBR3 cells.
- PDTC treatment led to the formation of a Raf1/14-3-3/PTPIP51 complex in SKBR3 cells.
- This complex formation suggests a translocation of PTPIP51 into the MAPK signaling pathway.
Conclusions:
- IKK-16 demonstrates selective inhibition of cell viability in SKBR3 cells.
- PTPIP51 may act as a crucial mediator connecting NFκB signaling to the MAPK pathway in SKBR3 cells.
- These findings highlight potential therapeutic targets for Her2-amplified breast cancer.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
11:27A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...